Spring Creek Capital’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Spring Creek Capital’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,000	Closed	-$61K	–	22
2022 Q1	$61K	Buy	+100,000	New	+$54.5K	﹤0.01%	534

Other funds holding DRTSW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return

Spring Creek Capital's DRTSW Position: Q2 2022 in Review

Spring Creek Capital sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 100,000 shares — an estimated $61K sold.

Spring Creek Capital first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $61K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

Spring Creek Capital reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 100,000 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $61K.
Spring Creek Capital first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
Spring Creek Capital's Alpha Tau Medical Warrant position peaked at $61K in Q1 2022.
37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.